Rising drug prices in America
October 20, 2015
Investigating Valeant Pharmaceuticals’ rise to the top by buying other drug companies and aggressively raising prices
A recent Wall Street Journal analysis of 30 top-selling drugs showed wholesale price increases averaged 76 percent from 2010 through 2014. That was more than eight times general inflation. Valeant Pharmaceuticals has become one of the most valuable drug companies in the world by buying other drug companies and often raising prices aggressively. And that has put the Canadian company and its executives under increasing scrutiny and pressure. Mary Snow has the story.